Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 3
2012 1
2013 1
2015 1
2016 1
2017 1
2018 2
2019 1
2020 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Surgical treatment of movement disorders.
Kluger BM, Klepitskaya O, Okun MS. Kluger BM, et al. Among authors: klepitskaya o. Neurol Clin. 2009 Aug;27(3):633-77, v. doi: 10.1016/j.ncl.2009.04.006. Neurol Clin. 2009. PMID: 19555825 Review.
Opicapone Pharmacokinetics and Effects on Catechol- O -Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa.
LeWitt P, Liang GS, Olanow CW, Kieburtz KD, Jimenez R, Olson K, Klepitskaya O, Loewen G. LeWitt P, et al. Among authors: klepitskaya o. Clin Neuropharmacol. 2023 Mar-Apr 01;46(2):43-50. doi: 10.1097/WNF.0000000000000538. Epub 2023 Jan 21. Clin Neuropharmacol. 2023. PMID: 36688497 Free PMC article. Clinical Trial.
The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease.
Mata IF, Jang Y, Kim CH, Hanna DS, Dorschner MO, Samii A, Agarwal P, Roberts JW, Klepitskaya O, Shprecher DR, Chung KA, Factor SA, Espay AJ, Revilla FJ, Higgins DS, Litvan I, Leverenz JB, Yearout D, Inca-Martinez M, Martinez E, Thompson TR, Cholerton BA, Hu SC, Edwards KL, Kim KS, Zabetian CP. Mata IF, et al. Among authors: klepitskaya o. Mol Neurodegener. 2015 Sep 24;10:50. doi: 10.1186/s13024-015-0045-4. Mol Neurodegener. 2015. PMID: 26399558 Free PMC article.
Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study.
Leehey MA, Liu Y, Hart F, Epstein C, Cook M, Sillau S, Klawitter J, Newman H, Sempio C, Forman L, Seeberger L, Klepitskaya O, Baud Z, Bainbridge J. Leehey MA, et al. Among authors: klepitskaya o. Cannabis Cannabinoid Res. 2020 Dec 15;5(4):326-336. doi: 10.1089/can.2019.0068. eCollection 2020. Cannabis Cannabinoid Res. 2020. PMID: 33381646 Free PMC article.
16 results